Treatment of arterial hypertension in the very elderly: A meta-analysis of clinical trials

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 4, 2011, Pages 221-228

  Schall, Petra ^a   Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antihypertensive treatment; Clinical endpoints; Elderly; Hypertension

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; COCHRANE LIBRARY; COMPARATIVE STUDY; HEART FAILURE; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; MORBIDITY; MORTALITY; REVIEW; STROKE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; VERY ELDERLY;

EID: 79955744847     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296191     Document Type: Review

References (31)

1. Franklin SS, Gustin W 4th., Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-15. (Pubitemid 27298437)
2. World Health Organisation International Society of Hypertension Writing Group. World Health Organisation(WHO)/ International Society of Hypertension (ISH) Statement on Managment of Hypertension. J Hypertens 2003;21:1983-92.
3. Pieper L, Wittchen HU, Glaesmer H, Klotsche J, Marz W, Stalla G, et al. Cardiovascular high-risk constellations in primary care. DETECT Study 2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005;48:1374-82.
4. Sharma AM, Wittchen HU, Kirch W, PittrowD, Ritz E, Göke B, et al. HYDRA Study Group. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004;22:479-86. (Pubitemid 38368480)
5. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann InternMed. 2002;136: 438-48. (Pubitemid 34234783)
6. Organisation for Economic Co-Operation and Development. Overview. Ageing and Transport Mobility Needs and Safety Issues, 2002, Available from: http://www.oecd.org/dataoecd/34/52/1907724.pdf, accessed 23/11/2010.
7. Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet. 1999;353:793-6.
8. Davidson RA, Caranasos GJ. Should the elderly hypertensive be treated? Evidence from clinical trials. Arch Intern Med. 1987;147:1933-7. (Pubitemid 18003351)
9. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8:393-405. (Pubitemid 20347070)
10. Thijs L, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens. 1992;10:1103-9.
11. Celis H, Fagard R, Staessen J, Thijs L, Amery A. The older hypertensive: assessment and treatment. Neth J Med. 1993;43:66-77.
12. Leonetti G, Cuspidi C, Fastidio M, Lonati L, Chianca R. Arterial hypertension as a risk factor in the elderly and its treatment. J Hypertens. 1992;2:3-7.
13. Bejan-Angoulvat T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomised controlled trials. J Hypertens 2010;28:1366-72.
14. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009;4:CD000028.
15. Beckett NS, Bulpitt Ch, Peters R, Fletcher AE, Staessen JA, Liu L, et al. Treatment of Hypertension in Patients 80 years of age or older. N Engl J Med. 2008;358:1887-98. (Pubitemid 351620109)
16. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115-27.
17. Moher D, Liberati A, Tetzlaff J, Altman DG; the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9.
18. Bulpitt CJ, Beckett NS, Cooke J, Dumitrascu DL, Gil-Extremera B, Nachev C, et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens. 2003;21:2409-17. (Pubitemid 38293581)
19. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1986;293:1145-51. (Pubitemid 16008923)
20. Casiglia E, Spolaore P, Mazza A, Ginocchio G, Colangeli G, Onesto C, et al. Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL). Jpn Heart J. 1994; 35:589-600. (Pubitemid 24356063)
21. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-64.
22. Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. J Gerontol. 1986;42:552-7.
23. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;8442:1349-54. (Pubitemid 15060905)
24. Lindholm LH, Hansson L, Dahlof B, Ekbom T, Hedner T, De Faire U, et al. The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report. Blood Press. 1996;5:300-4. (Pubitemid 26290694)
25. Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2000;2:CD000028.
26. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM, et al. Incidence, risk and case fatality of first ever stroke in the elderly population: The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74:317-21. (Pubitemid 36259354)
27. Hoppe UC, Böhm M, Drexler H, Hasenfuß G, Lemke B, Osterspey A, Pauschinger M. Therapie der chronischen und akuten Herzinsuffizienz. UPDATE 2009. Herz- und Kreislaufforschung e.V. German Cardiac Society. Available from: http://leitlinien.dgk.org/images/pdf/leitlinien-pocket/2009-pll-1- herzinsuffizienz-update2009.pdf, accessed 23/ 11/2010.
28. Ogihara T, Nakao K, Fukui T, Fukiyama K, Fujimoto A, Ueshima K, et al. The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res. 2008;31:1595-601.
29. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751-62. (Pubitemid 47356612)
30. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
31. Jamerson KA, Bakris GL, Wun CC, Dahlöf B, Lefkowitz M, Manfreda S, et al. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension. AmJ Hypertens 2004;17:793-801. (Pubitemid 39201095)